Ana Jaklenec

Ana Jaklenec

Auto-generated profile, based on publicly available information

Ana Jaklenec

David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2016 in Nano Letters
Verified
Journal Article
Closed access
MOMatthias A. Oberli
Matthias A. Oberli
ARAndreas M. Reichmuth
Andreas M. Reichmuth
JDJ. Robert Dorkin
J. Robert Dorkin
MMMichael Mitchell
Michael Mitchell
OFOwen S. Fenton
Owen S. Fenton
DBDaniel Blankschtein
Daniel Blankschtein

14 April 2016 in Therapeutic Delivery
Verified
Journal Article
Open access
ARAndreas M Reichmuth
Andreas M Reichmuth
MOMatthias A Oberli
Matthias A Oberli
AJAna Jaklenec
Ana Jaklenec
RLRobert Langer
Robert Langer
DBDaniel Blankschtein
Daniel Blankschtein
MRNA vaccines elicit a potent immune response including antibodies and cytotoxic T cells. mRNA vaccines are currently evaluated in clinical trials for cancer immunotherapy applications, but also have great potential as prophylactic vaccines. Efficient delivery of mRNA vaccines will be key for their success and translation to the clinic. Among potential nonviral vectors, lipid nanoparticles are particularly promising. Indeed, lipid nanoparticles can be synthesized with relative ease in a scalable manner, protect the mRNA against degradation, facilitate endosomal escape, can be targeted to the desired cell type by surface decoration with ligands, and as needed, can be codelivered with adjuvants.

12 September 2016 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
AAAaron C. Anselmo
Aaron C. Anselmo
KMKevin J. McHugh
Kevin J. McHugh
JWJamie Webster
Jamie Webster
RLRobert Langer
Robert Langer
AJAna Jaklenec
Ana Jaklenec

22 February 2018 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
KMKevin J. McHugh
Kevin J. McHugh
LJLihong Jing
Lihong Jing
ABAdam M. Behrens
Adam M. Behrens
SJSurangi Jayawardena
Surangi Jayawardena
WTWen Tang
Wen Tang
AJAna Jaklenec
Ana Jaklenec

15 September 2017 in Science
Verified
Journal Article
Open access
PDF file
KMKevin J. McHugh
Kevin J. McHugh
TNThanh D. Nguyen
Thanh D. Nguyen
ALAllison R. Linehan
Allison R. Linehan
DYDavid Yang
David Yang
ABAdam M. Behrens
Adam M. Behrens
AJAna Jaklenec
Ana Jaklenec
Technology used for computer chip manufacturing is combined with soft lithography to produce small polymeric structures.

12 August 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
XLXueguang Lu
Xueguang Lu
LMLei Miao
Lei Miao
WGWenting Gao
Wenting Gao
ZCZiqi Chen
Ziqi Chen
KMKevin J. McHugh
Kevin J. McHugh
AJAna Jaklenec
Ana Jaklenec
Microfabricated particles mimic multiple intratumoral injections of STING agonist over weeks to improve ease of use and decrease metastasis.